4D Molecular Therapeutics (NASDAQ:FDMT) Sees Large Volume Increase

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 974,797 shares changed hands during mid-day trading, a decline of 25% from the previous session’s volume of 1,293,429 shares.The stock last traded at $30.87 and had previously closed at $33.21. Wall Street Analyst Weigh In Several […]

Related Keywords

Canada ,David Kirn ,Leerink Partnrs ,Securities Exchange Commission ,International Assets Investment Management ,Lazard Asset Management ,Ensign Peak Advisors Inc ,Nasdaq ,D Molecular Therapeutics Company Profile ,Royal Bank ,Goldman Sachs Group ,D Molecular Therapeutics Inc ,Molecular Therapeutics ,Get Free Report ,Molecular Therapeutics Stock Down ,Exchange Commission ,Global Investors Lp Viking ,Assets Investment Management ,Asset Management ,Peak Advisors Inc ,Molecular Therapeutics Company ,Molecular Therapeutics Daily ,